About Chengdu Fifth People's Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
3
Sichuan Cancer Hospital and Research Institute
2
Clinical Trials at Chengdu Fifth People's Hospital
During the past decade, Chengdu Fifth People's Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on
average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC
2018-10-16
2020-11-01
Unknown status
88
Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC
2018-12-06
2021-03-10
Unknown status
62
A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions
2019-06-25
2021-02-05
Completed
333
Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A
2019-12-07
2020-05-18
Completed
172
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)
2019-12-09
2021-11-24
Completed
917
Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus
2021-09-30
2025-04-01
Recruiting
672
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time
2022-06-03
2024-06-10
Active, not recruiting
912
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
2022-10-11
2027-10-07
Recruiting
15,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Chengdu Fifth People's Hospital" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Sichuan Cancer Hospital and Research Institute" with 2 trials
sponsored, "Guangdong Raynovent Biotech Co., Ltd" with 1 trials sponsored, "PegBio Co., Ltd." with 1 trials sponsored and "Sichuan Academy of Medical Sciences"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Chengdu Fifth People's Hospital"
#1 collaborator was "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials as a collaborator and "Sichuan Provincial People's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Chengdu Fifth People's Hospital
According to Clinical.Site data, the most researched conditions in "Chengdu Fifth People's Hospital" are
"Lung Cancer Metastatic" (2 trials), "Type 2 Diabetes" (2 trials), "Abnormal Mucus Secretions" (1 trials), "Acute Ischemic Stroke" (1 trials) and "Alteplase" (1 trials). Many other conditions were trialed in "Chengdu Fifth People's Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Chengdu Fifth People's Hospital
Most popular intervention types in "Chengdu Fifth People's Hospital" are "Drug" (9 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Tirzepatide" (2 trials), "Ambroxol hydrochloride 30 mg" (1 trials), "Anlotinib Hydrochloride" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Chengdu Fifth People's Hospital
The vast majority of trials in "Chengdu Fifth People's Hospital" are
9 trials for "All" genders.
Clinical Trials Status at Chengdu Fifth People's Hospital
Currently, there are NaN active trials in "Chengdu Fifth People's Hospital".
1 are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Chengdu Fifth People's Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Chengdu Fifth People's Hospital, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".